Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/S ratio is N/A as of 2026-10-06T18:27:03.916Z.
Calculation as of: 2026-10-06T18:27:03.916Z.
Quote observation: 2026-10-06T18:25:02.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 771dc6670e9772695969b0bf6104b917a4d7f40f340cdb77ec2424dd20cacd43
Current P/S: FMP quote market capitalization / TTM revenue. Historical estimates use price and reported weighted-average shares; daily points use adjusted close × quarterly weighted-average shares / TTM revenue. Historical series through 2026-08-13.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PS RATIO
N/A
PS RATIO AVG TTM
892.24
PS RATIO AVG 3Y
805.15
PS RATIO AVG 5Y
576.66
PS RATIO AVG 10Y
N/A
PS RATIO AVG 15Y
N/A
PS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$1.40B
PS Ratio
255.42
TTM Avg
270.55
3Y Avg
122.63
5Y Avg
108.45
Market Cap
$1.43B
PS Ratio
2.00
TTM Avg
3.96
3Y Avg
6.31
5Y Avg
7.98
Market Cap
$1.33B
PS Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | PS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Inhibrx Biosciences Inc. (INBX) | $1.39B | N/A | 892.24 | 805.15 | 576.66 |
| Taysha Gene Therapies, Inc. (TSHA)vs › | $1.40B | 255.42 | 270.55 | 122.63 | 108.45 |
| The Pennant Group, Inc. (PNTG)vs › | $1.41B | 1.28 | 1.22 | 1.22 | 1.12 |
| Kailera Therapeutics, Inc. (KLRA)vs › | $1.41B | N/A | N/A | N/A | N/A |
| AnaptysBio, Inc. (ANAB)vs › | $1.42B | 5.96 | 6.28 | 11.75 | 20.01 |
| Omeros Corporation (OMER)vs › | $1.34B | 34.96 | 78.10 | 78.10 | 55.15 |
| Braveheart Bio, Inc. (BRVE)vs › | $1.43B | N/A | N/A | N/A | N/A |
| Ultragenyx Pharmaceutical Inc. (RARE)vs › | $1.43B | 2.00 | 3.96 | 6.31 | 7.98 |
| Hemab Therapeutics Holdings, Inc. Common Stock (COAG)vs › | $1.33B | N/A | N/A | N/A | N/A |
| Healthcare Services Group, Inc. (HCSG)vs › | $1.44B | 0.77 | 0.80 | 0.61 | 0.64 |
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $0 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-14 |
| Q4 FY2025Period ended 2025-12-31 | $0 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-19 |
| Q1 FY2026Period ended 2026-03-31 | $0 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-14 |
| Q2 FY2026Period ended 2026-06-30 | $0 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-13 |
| TTM revenue | $0 |
The current P/S calculation cannot be reconciled from the stored quote and revenue inputs.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
P/S Ratio
N/A
Market Cap / Trailing Twelve-Month Revenue
PS Ratio = Market Cap / Revenue (TTM)
The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PS RATIO |
|---|---|
| 2026-08-13 | 1163.00 |
| 2026-08-12 | 1179.19 |
| 2026-08-11 | 1107.49 |
| 2026-08-10 | 1116.25 |
| 2026-08-07 | 1062.90 |
| 2026-08-06 | 1028.49 |
| 2026-08-05 | 1005.71 |
| 2026-08-04 | 1001.40 |
| 2026-08-03 | 991.69 |
| 2026-07-31 | 983.65 |
| 2026-07-30 | 1015.78 |
| 2026-07-29 | 950.09 |
| 2026-07-28 | 955.24 |
| 2026-07-27 | 988.45 |
| 2026-07-24 | 977.66 |
| 2026-07-23 | 1019.02 |
| 2026-07-22 | 1030.05 |
| 2026-07-21 | 1050.31 |
| 2026-07-20 | 1008.11 |
| 2026-07-17 | 1047.67 |
| 2026-07-16 | 1067.81 |
| 2026-07-15 | 1093.59 |
| 2026-07-14 | 1117.44 |
| 2026-07-13 | 1104.98 |
| 2026-07-10 | 1115.05 |
| 2026-07-09 | 1245.00 |
| 2026-07-08 | 1164.08 |
| 2026-07-07 | 1207.84 |
| 2026-07-06 | 1164.56 |
| 2026-07-02 | 1169.83 |
| 2026-07-01 | 1138.18 |
| 2026-06-30 | 1135.91 |
| 2026-06-29 | 1144.90 |
| 2026-06-26 | 1136.63 |
| 2026-06-25 | 1142.62 |
| 2026-06-24 | 1140.58 |
| 2026-06-23 | 1113.85 |
| 2026-06-22 | 1118.52 |
| 2026-06-18 | 1115.53 |
| 2026-06-17 | 1129.31 |
| 2026-06-16 | 1116.25 |
| 2026-06-15 | 1121.04 |
| 2026-06-12 | 1105.34 |
| 2026-06-11 | 1121.40 |
| 2026-06-10 | 1072.61 |
| 2026-06-09 | 1068.17 |
| 2026-06-08 | 1068.53 |
| 2026-06-05 | 1043.12 |
| 2026-06-04 | 1093.95 |
| 2026-06-03 | 1141.54 |
| 2026-06-02 | 1122.48 |
| 2026-06-01 | 1190.33 |
| 2026-05-29 | 1246.92 |
| 2026-05-28 | 1246.56 |
| 2026-05-27 | 1234.81 |
| 2026-05-26 | 1280.97 |
| 2026-05-22 | 1214.67 |
| 2026-05-21 | 1325.56 |
| 2026-05-20 | 1318.85 |
| 2026-05-19 | 1312.86 |
| 2026-05-18 | 1268.38 |
| 2026-05-15 | 1302.43 |
| 2026-05-14 | 1383.82 |
| 2026-05-13 | 1405.15 |
| 2026-05-12 | 1294.36 |
| 2026-05-11 | 1519.87 |
| 2026-05-08 | 1600.52 |
| 2026-05-07 | 1483.42 |
| 2026-05-06 | 1689.75 |
| 2026-05-05 | 1526.30 |
| 2026-05-04 | 1524.28 |
| 2026-05-01 | 1534.29 |
| 2026-04-30 | 1539.29 |
| 2026-04-29 | 1486.99 |
| 2026-04-28 | 1556.68 |
| 2026-04-27 | 1565.97 |
| 2026-04-24 | 1537.50 |
| 2026-04-23 | 1428.74 |
| 2026-04-22 | 1371.08 |
| 2026-04-21 | 1001.65 |
| 2026-04-20 | 981.52 |
| 2026-04-17 | 1051.09 |
| 2026-04-16 | 990.10 |
| 2026-04-15 | 995.93 |
| 2026-04-14 | 991.05 |
| 2026-04-13 | 922.79 |
| 2026-04-10 | 896.70 |
| 2026-04-09 | 902.42 |
| 2026-04-08 | 799.72 |
| 2026-04-07 | 742.78 |
| 2026-04-06 | 759.10 |
| 2026-04-02 | 756.84 |
| 2026-04-01 | 798.77 |
| 2026-03-31 | 800.92 |
| 2026-03-30 | 713.36 |
| 2026-03-27 | 695.60 |
| 2026-03-26 | 783.76 |
| 2026-03-25 | 791.74 |
| 2026-03-24 | 751.95 |
| 2026-03-23 | 769.94 |
| 2026-03-20 | 725.74 |
| 2026-03-19 | 717.18 |
| 2026-03-18 | 759.42 |
| 2026-03-17 | 770.69 |
| 2026-03-16 | 765.72 |
| 2026-03-13 | 759.97 |
| 2026-03-12 | 766.16 |
| 2026-03-11 | 812.60 |
| 2026-03-10 | 791.92 |
| 2026-03-09 | 794.46 |
| 2026-03-06 | 764.83 |
| 2026-03-05 | 781.20 |
| 2026-03-04 | 825.09 |
| 2026-03-03 | 821.77 |
| 2026-03-02 | 856.71 |
| 2026-02-27 | 819.56 |
| 2026-02-26 | 853.83 |
| 2026-02-25 | 887.44 |
| 2026-02-24 | 878.93 |
| 2026-02-23 | 846.76 |
| 2026-02-20 | 869.42 |
| 2026-02-19 | 896.40 |
| 2026-02-18 | 901.93 |
| 2026-02-17 | 870.86 |
| 2026-02-13 | 838.02 |
| 2026-02-12 | 907.78 |
| 2026-02-11 | 906.46 |
| 2026-02-10 | 920.94 |
| 2026-02-09 | 956.21 |
| 2026-02-06 | 927.68 |
| 2026-02-05 | 901.37 |
| 2026-02-04 | 912.76 |
| 2026-02-03 | 940.62 |
| 2026-02-02 | 909.11 |
| 2026-01-30 | 843.22 |
| 2026-01-29 | 802.20 |
| 2026-01-28 | 817.90 |
| 2026-01-27 | 812.48 |
| 2026-01-26 | 796.01 |
| 2026-01-23 | 825.42 |
| 2026-01-22 | 878.82 |
| 2026-01-21 | 830.28 |
| 2026-01-20 | 805.96 |
| 2026-01-16 | 799.00 |
| 2026-01-15 | 793.80 |
| 2026-01-14 | 839.46 |
| 2026-01-13 | 810.16 |
| 2026-01-12 | 839.57 |
| 2026-01-09 | 805.52 |
| 2026-01-08 | 831.39 |
| 2026-01-07 | 839.46 |
| 2026-01-06 | 841.34 |
| 2026-01-05 | 849.96 |
| 2026-01-02 | 829.62 |
| 2025-12-31 | 873.40 |
| 2025-12-30 | 862.12 |
| 2025-12-29 | 876.39 |
| 2025-12-26 | 886.78 |
| 2025-12-24 | 888.44 |
| 2025-12-23 | 863.23 |
| 2025-12-22 | 967.60 |
| 2025-12-19 | 952.23 |
| 2025-12-18 | 943.27 |
| 2025-12-17 | 918.62 |
| 2025-12-16 | 901.81 |
| 2025-12-15 | 842.56 |
| 2025-12-12 | 879.70 |
| 2025-12-11 | 908.89 |
| 2025-12-10 | 934.32 |
| 2025-12-09 | 982.74 |
| 2025-12-08 | 1033.82 |
| 2025-12-05 | 989.15 |
| 2025-12-04 | 966.38 |
| 2025-12-03 | 917.18 |
| 2025-12-02 | 909.33 |
| 2025-12-01 | 892.97 |
| 2025-11-28 | 930.01 |
| 2025-11-26 | 924.92 |
| 2025-11-25 | 914.09 |
| 2025-11-24 | 895.62 |
| 2025-11-21 | 927.91 |
| 2025-11-20 | 882.69 |
| 2025-11-19 | 908.12 |
| 2025-11-18 | 857.81 |
| 2025-11-17 | 855.16 |
| 2025-11-14 | 874.84 |
| 2025-11-13 | 824.44 |
| 2025-11-12 | 810.08 |
| 2025-11-11 | 860.02 |
| 2025-11-10 | 872.84 |
| 2025-11-07 | 891.51 |
| 2025-11-06 | 894.82 |
| 2025-11-05 | 908.97 |
| 2025-11-04 | 905.87 |
| 2025-11-03 | 899.80 |
| 2025-10-31 | 902.23 |
| 2025-10-30 | 867.42 |
| 2025-10-29 | 851.29 |
| 2025-10-28 | 756.72 |
| 2025-10-27 | 650.21 |
| 2025-10-24 | 632.97 |
| 2025-10-23 | 313.34 |
| 2025-10-22 | 348.25 |
| 2025-10-21 | 414.54 |
| 2025-10-20 | 422.28 |
| 2025-10-17 | 411.56 |
| 2025-10-16 | 404.38 |
| 2025-10-15 | 397.09 |
| 2025-10-14 | 384.60 |
| 2025-10-13 | 379.85 |
| 2025-10-10 | 358.75 |
| 2025-10-09 | 386.70 |
| 2025-10-08 | 371.34 |
| 2025-10-07 | 370.13 |
| 2025-10-06 | 386.26 |
| 2025-10-03 | 393.88 |
| 2025-10-02 | 387.47 |
| 2025-10-01 | 375.43 |
| 2025-09-30 | 372.12 |
| 2025-09-29 | 356.98 |
| 2025-09-26 | 361.07 |
| 2025-09-25 | 351.90 |
| 2025-09-24 | 328.14 |
| 2025-09-23 | 319.30 |
| 2025-09-22 | 299.64 |
| 2025-09-19 | 304.94 |
| 2025-09-18 | 294.44 |
| 2025-09-17 | 293.23 |
| 2025-09-16 | 293.56 |
| 2025-09-15 | 300.41 |
| 2025-09-12 | 304.06 |
| 2025-09-11 | 314.33 |
| 2025-09-10 | 305.49 |
| 2025-09-09 | 326.93 |
| 2025-09-08 | 321.51 |
| 2025-09-05 | 311.35 |
| 2025-09-04 | 306.27 |
| 2025-09-03 | 307.15 |
| 2025-09-02 | 305.16 |
| 2025-08-29 | 311.57 |
| 2025-08-28 | 308.03 |
| 2025-08-27 | 302.73 |
| 2025-08-26 | 286.38 |
| 2025-08-25 | 276.66 |
| 2025-08-22 | 276.21 |
| 2025-08-21 | 266.93 |
| 2025-08-20 | 269.70 |
| 2025-08-19 | 254.12 |
| 2025-08-18 | 263.73 |
| 2025-08-15 | 257.76 |
| 2025-08-14 | 264.50 |
| 2025-08-13 | 1822.90 |
| 2025-08-12 | 1695.29 |
| 2025-08-11 | 1655.08 |
| 2025-08-08 | 1628.78 |
| 2025-08-07 | 1650.44 |
| 2025-08-06 | 1622.59 |
| 2025-08-05 | 1619.50 |
| 2025-08-04 | 1686.01 |
| 2025-08-01 | 1670.54 |
Showing the most recent 260 of 1,502 data points. The chart above shows the full history.
